Catalog preview
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in metabolic care for adults pursuing structured weight management.
Item details are being reviewed. Prices and purchase availability are not final.
Find your starting point →Know what you're considering.
Overview
Tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism may support insulin sensitivity, satiety, and slower gastric emptying. In adults pursuing weight care, it is used alongside nutrition and movement changes to support sustainable progress.
Ingredients
Tirzepatide
Use & directions
Weekly subcutaneous injection with gradual titration. Dose individualized by your clinician.
Important information.
Side effects
Common: nausea, vomiting, diarrhea, constipation, decreased appetite, fatigue. Less common: pancreatitis, gallbladder events, injection-site reactions. Contact your clinician for severe abdominal pain.
Safety & precautions
Important Safety Information — Boxed Warning. Carries the same thyroid C-cell tumor warning as other GLP-1 receptor agonists. Contraindicated with personal or family history of medullary thyroid carcinoma or MEN 2. Not for use in pregnancy. Full medical and medication history required.
Read the information for the exact product and formulation. Ask your clinician or pharmacist about suitability, interactions and any questions.
Service & renewal
Review the terms attached to the selected offer before continuing.
Understand service terms →Shipping
Handling, collection and delivery depend on the product and fulfillment partner.
View shipping information →Questions
Keep health questions in your secure portal. Support can help with general ordering questions.
Get help →